PAVmed Inc. (PAVM)
NASDAQ: PAVM · IEX Real-Time Price · USD
0.710
-0.054 (-7.07%)
At close: Jul 2, 2024, 4:00 PM
0.740
+0.030 (4.23%)
After-hours: Jul 2, 2024, 7:32 PM EDT
PAVmed Stock Forecast
PAVM's stock price has decreased by -87.57% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for PAVmed stock has a target of 8.61, which predicts an increase of 1,112.68% from the current stock price of 0.71.
Analyst Consensus: Hold
* Price targets were last updated on Aug 18, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for PAVmed is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $8.61 | Hold | Reiterates | $8.61 | +1,112.68% | Aug 18, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $25 → $9.23 | Buy → Hold | Downgrades | $25 → $9.23 | +1,200.00% | Jan 20, 2023 |
Lake Street | Lake Street | Strong Buy Maintains $31 → $9.23 | Strong Buy | Maintains | $31 → $9.23 | +1,200.00% | Jan 18, 2023 |
Lake Street | Lake Street | Strong Buy Maintains $43 → $31 | Strong Buy | Maintains | $43 → $31 | +4,230.99% | Aug 17, 2022 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $49 | Buy | Initiates | $49 | +6,829.58% | Mar 30, 2021 |
Financial Forecast
Revenue This Year
5.62M
from 2.45M
Increased by 129.04%
Revenue Next Year
15.96M
from 5.62M
Increased by 184.21%
EPS This Year
-6.64
from -9.16
EPS Next Year
-3.75
from -6.64
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 8.3M | 39.7M | 105.6M | 192.8M | 250.5M |
Avg | 5.6M | 16.0M | 102.6M | 187.3M | 243.4M |
Low | 4.5M | 7.1M | 98.6M | 179.9M | 233.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 238.3% | 606.7% | 561.8% | 87.9% | 33.8% |
Avg | 129.0% | 184.2% | 542.9% | 82.5% | 30.0% |
Low | 83.8% | 27.3% | 517.7% | 75.4% | 24.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -6.47 | -1.95 | -0.50 |
Avg | -6.64 | -3.75 | -0.49 |
Low | -7.04 | -5.79 | -0.47 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.